Delivery Order SPE2DB20D3303-SPE2DB25FA1ZK
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,309.28 firm fixed-price delivery order is for the supply of Timolol 0.5% Gel-Solution, a medication used for the treatment of eye conditions. The contract has a period of performance through January 31, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Timolol 0.5% gel-solution, a pharmaceutical product used for the treatment of glaucoma. The contract has a ceiling value of $2,026.35 and a completion date of March 27, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,136.10 firm-fixed-price delivery order is for the supply of Timolol 0.5% Gel-Solution, a medication used to treat glaucoma. The award has an ultimate completion date of May 16, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,090.26 contract is for the supply of Timolol 0.25% Gel-Solution 5ML, a medication used to treat certain eye conditions. This Delivery Order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,413.66, is for the procurement of Timolol 0.25% Gel-Solution 5ML, a medication used to treat certain eye conditions. The delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Timolol 0.5% Gel-Solution 5ML, a prescription eye medication, with a ceiling value of $1,659.44 and a period of performance through April 2025. The contract is not set aside and was awarded as a firm-fixed-price delivery order. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Timolol 0.25% gel-solution, a medication used to treat glaucoma. The contract has a ceiling value of $8,363.49 and runs through September 25, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Timolol Maleate 0.5% eye drop unit dose packets (60-count) valued at $1,199.16 with a firm fixed price structure. The contract was competitively awarded without a set-aside designation and carries an ultimate completion date of July 22, 2025, one day after the July 21, 2025 award date. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken,...
- This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Timolol 0.5% Gel-Solution, a pharmaceutical product. The contract has a firm fixed price of $2,833.08 and a completion date of October 8, 2024. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor, and this delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that the company holds with the DLA Troop Support...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Timolol 0.5% Gel-Solution 5mL. The delivery order, valued at $15,888.80, is issued against an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that enables Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA1ZKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Timolol 0.5% Gel-Solution 5ML, with a ceiling value of $3,427.07. This competitively awarded, non-set-aside contract is classified as a firm fixed price delivery order with an ultimate completion date of July 31, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in supplying medications, medical devices, and healthcare commodities to defense and veteran healthcare systems. The Timolol product supplied under this delivery order is an ophthalmic medication used in treating glaucoma and ocular hypertension, supporting the medical supply needs of military and federal healthcare beneficiaries. As a prime contractor with an extensive portfolio of federal pharmaceutical awards, AmerisourceBergen demonstrates significant capability in meeting competitive federal procurement requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 7/30/25 |